Rho Recognized by Triangle Business Journal with Fast 50 Award


Chapel Hill, NC – November 5, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Triangle Business Journal has named the company a winner of its Fast 50 Award. The annual program honors the area's most dynamic, growing privately held companies. By doubling its commercial business in the last six years and establishing and continuing collaborations with organizations in its Federal Systems Division, Rho has experienced unprecedented growth across the company.

“We have amazing employees who care tremendously about the work they do, the patients they serve, and each other.  Thanks to them, we are able to serve more clients and grow our business,” said Laura Helms Reece, Dr.P.H., co-chief executive officer at Rho. “We are honored to be recognized as one of the fastest growing companies in the Triangle, and we’re excited for the opportunities this growth will bring.”

Due to the expedient growth, the company will move its headquarters to a new 159,000-square-foot headquarters building in Research Triangle Park (RTP), North Carolina. The new building will be 50 percent larger than Rho’s current location, allowing plenty of space for continued expansion. The building, scheduled to be completed in early 2019, is a testament to Rho’s expanding business and commitment to its roots in the Triangle.

Rho, along with 50 other local companies, will be recognized during a special award ceremony on Monday, November 5, at the Raleigh Convention Center. This is the first Fast 50 award win for the CRO.  

To learn more about Rho, please visit www.rhoworld.com.

About Rho

Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 34 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.

Back to news